Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA

Large Cap | Pharmaceuticals & Drugs

1664.25

-4.95 (-0.30%)

< Home < Back

Sun Pharmaceutical Industries submits analyst meet intimation

Date: 17-10-2023

Sun Pharmaceutical Industries has informed that it enclosed press release relating to Earnings Call for financial results for the second quarter ending September 30, 2023.

The above information is a part of company’s filings submitted to BSE.